JP2012525201A - イオン置換されたリン酸カルシウムコーティング - Google Patents
イオン置換されたリン酸カルシウムコーティング Download PDFInfo
- Publication number
- JP2012525201A JP2012525201A JP2012508432A JP2012508432A JP2012525201A JP 2012525201 A JP2012525201 A JP 2012525201A JP 2012508432 A JP2012508432 A JP 2012508432A JP 2012508432 A JP2012508432 A JP 2012508432A JP 2012525201 A JP2012525201 A JP 2012525201A
- Authority
- JP
- Japan
- Prior art keywords
- ion
- ions
- coating
- substrate
- phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 144
- 239000011248 coating agent Substances 0.000 title claims abstract description 112
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 title claims abstract description 66
- 239000001506 calcium phosphate Substances 0.000 title claims abstract description 63
- 235000011010 calcium phosphates Nutrition 0.000 title claims abstract description 59
- 229910000389 calcium phosphate Inorganic materials 0.000 title claims abstract description 58
- 150000002500 ions Chemical group 0.000 title claims description 84
- 238000000034 method Methods 0.000 claims abstract description 58
- 239000000758 substrate Substances 0.000 claims abstract description 57
- 239000000243 solution Substances 0.000 claims description 45
- 229910052712 strontium Inorganic materials 0.000 claims description 41
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 36
- 238000006467 substitution reaction Methods 0.000 claims description 32
- 239000007864 aqueous solution Substances 0.000 claims description 26
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 22
- 230000015572 biosynthetic process Effects 0.000 claims description 21
- 239000011701 zinc Substances 0.000 claims description 21
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 18
- 229910052710 silicon Inorganic materials 0.000 claims description 17
- 239000011575 calcium Substances 0.000 claims description 16
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 15
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 15
- 229910001424 calcium ion Inorganic materials 0.000 claims description 14
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 13
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 13
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 13
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 12
- 229910001414 potassium ion Inorganic materials 0.000 claims description 12
- 229910001415 sodium ion Inorganic materials 0.000 claims description 12
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000010703 silicon Substances 0.000 claims description 11
- 239000011734 sodium Substances 0.000 claims description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 10
- 229910052791 calcium Inorganic materials 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 9
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 9
- 229940085991 phosphate ion Drugs 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 8
- 238000007654 immersion Methods 0.000 claims description 7
- 229910052725 zinc Inorganic materials 0.000 claims description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 125000000129 anionic group Chemical group 0.000 claims description 5
- 125000002091 cationic group Chemical group 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 229910052788 barium Inorganic materials 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 238000002048 anodisation reaction Methods 0.000 claims description 3
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 3
- KVEAILYLMGOETO-UHFFFAOYSA-H dicalcium magnesium diphosphate Chemical compound P(=O)([O-])([O-])[O-].[Mg+2].[Ca+2].[Ca+2].P(=O)([O-])([O-])[O-] KVEAILYLMGOETO-UHFFFAOYSA-H 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 1
- 239000010936 titanium Substances 0.000 description 66
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 56
- 229910052719 titanium Inorganic materials 0.000 description 56
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 52
- 239000002953 phosphate buffered saline Substances 0.000 description 47
- 239000007943 implant Substances 0.000 description 45
- 210000000988 bone and bone Anatomy 0.000 description 33
- 238000001878 scanning electron micrograph Methods 0.000 description 31
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical class [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 30
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 28
- 238000011534 incubation Methods 0.000 description 28
- 238000005240 physical vapour deposition Methods 0.000 description 23
- 229910052500 inorganic mineral Inorganic materials 0.000 description 20
- 235000010755 mineral Nutrition 0.000 description 20
- 239000011707 mineral Substances 0.000 description 20
- 238000001727 in vivo Methods 0.000 description 17
- 230000008569 process Effects 0.000 description 16
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 15
- 238000002441 X-ray diffraction Methods 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical class [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 14
- 239000011777 magnesium Substances 0.000 description 11
- 229910001427 strontium ion Inorganic materials 0.000 description 11
- 238000005011 time of flight secondary ion mass spectroscopy Methods 0.000 description 10
- 229910052586 apatite Inorganic materials 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 8
- 229910021641 deionized water Inorganic materials 0.000 description 8
- 238000000151 deposition Methods 0.000 description 8
- 230000008021 deposition Effects 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000002042 time-of-flight secondary ion mass spectrometry Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000033558 biomineral tissue development Effects 0.000 description 7
- 239000000460 chlorine Substances 0.000 description 7
- -1 fluoride ions Chemical class 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000011164 ossification Effects 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 239000004408 titanium dioxide Substances 0.000 description 6
- 229910010413 TiO 2 Inorganic materials 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000000975 bioactive effect Effects 0.000 description 5
- 230000003592 biomimetic effect Effects 0.000 description 5
- 238000001941 electron spectroscopy Methods 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000000845 cartilage Anatomy 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229910052587 fluorapatite Inorganic materials 0.000 description 4
- 229940077441 fluorapatite Drugs 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 239000012890 simulated body fluid Substances 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 4
- 235000019731 tricalcium phosphate Nutrition 0.000 description 4
- 229940078499 tricalcium phosphate Drugs 0.000 description 4
- 208000006386 Bone Resorption Diseases 0.000 description 3
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 230000024279 bone resorption Effects 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- XLUBVTJUEUUZMR-UHFFFAOYSA-B silicon(4+);tetraphosphate Chemical group [Si+4].[Si+4].[Si+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XLUBVTJUEUUZMR-UHFFFAOYSA-B 0.000 description 3
- 235000013024 sodium fluoride Nutrition 0.000 description 3
- PWYYWQHXAPXYMF-UHFFFAOYSA-N strontium(2+) Chemical group [Sr+2] PWYYWQHXAPXYMF-UHFFFAOYSA-N 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- 229910001069 Ti alloy Inorganic materials 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 239000005313 bioactive glass Substances 0.000 description 2
- 239000003462 bioceramic Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000008468 bone growth Effects 0.000 description 2
- 230000010478 bone regeneration Effects 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 239000004053 dental implant Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- DHEQXMRUPNDRPG-UHFFFAOYSA-N strontium nitrate Chemical compound [Sr+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O DHEQXMRUPNDRPG-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 229940122361 Bisphosphonate Drugs 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100496858 Mus musculus Colec12 gene Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000000026 X-ray photoelectron spectrum Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000011882 arthroplasty Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000005312 bioglass Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 150000004663 bisphosphonates Chemical class 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- GFIKIVSYJDVOOZ-UHFFFAOYSA-L calcium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [Ca+2].[O-]P([O-])(F)=O GFIKIVSYJDVOOZ-UHFFFAOYSA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000005524 ceramic coating Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- BCAARMUWIRURQS-UHFFFAOYSA-N dicalcium;oxocalcium;silicate Chemical compound [Ca+2].[Ca+2].[Ca]=O.[O-][Si]([O-])([O-])[O-] BCAARMUWIRURQS-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical group 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000002241 glass-ceramic Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009616 inductively coupled plasma Methods 0.000 description 1
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229910000392 octacalcium phosphate Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000007745 plasma electrolytic oxidation reaction Methods 0.000 description 1
- 238000007750 plasma spraying Methods 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- KOJVPUVZRJMDIO-UHFFFAOYSA-M sodium oxygen(2-) titanium(4+) fluoride Chemical compound [F-].[Na+].[O-2].[Ti+4] KOJVPUVZRJMDIO-UHFFFAOYSA-M 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- YIGWVOWKHUSYER-UHFFFAOYSA-F tetracalcium;hydrogen phosphate;diphosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O YIGWVOWKHUSYER-UHFFFAOYSA-F 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229910021534 tricalcium silicate Inorganic materials 0.000 description 1
- 235000019976 tricalcium silicate Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/32—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
- A61L31/086—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials For Medical Uses (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Paints Or Removers (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0900560A SE535536C2 (sv) | 2009-04-27 | 2009-04-27 | Jonsubstituerade hydroxiapatitytbeläggningar |
| SE0900560-4 | 2009-04-27 | ||
| PCT/SE2010/050461 WO2010126436A1 (en) | 2009-04-27 | 2010-04-26 | Ion substituted calcium phosphate coatings |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012525201A true JP2012525201A (ja) | 2012-10-22 |
| JP2012525201A5 JP2012525201A5 (enExample) | 2013-06-20 |
Family
ID=43032394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012508432A Pending JP2012525201A (ja) | 2009-04-27 | 2010-04-26 | イオン置換されたリン酸カルシウムコーティング |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120087954A1 (enExample) |
| EP (1) | EP2424580A4 (enExample) |
| JP (1) | JP2012525201A (enExample) |
| CN (1) | CN102438671A (enExample) |
| SE (1) | SE535536C2 (enExample) |
| WO (1) | WO2010126436A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101423982B1 (ko) | 2012-08-10 | 2014-08-13 | 서울대학교산학협력단 | 휘트록카이트 및 그 제조 방법 |
| WO2014174437A1 (en) * | 2013-04-22 | 2014-10-30 | Sandvik Intellectual Property Ab | Method for drug loading hydroxyapatite coated implant surfaces |
| EP3010557B1 (en) | 2013-06-21 | 2019-08-21 | Stryker European Holdings I, LLC | Co-precipitation of tobramycin into hydroxyapatite coatings |
| WO2015003756A1 (en) | 2013-07-11 | 2015-01-15 | Stryker Leibinger Gmbh & Co. Kg | Fixation assembly with a flexible elongated member for securing parts of a sternum |
| WO2015028100A1 (en) | 2013-09-02 | 2015-03-05 | Stryker Trauma Gmbh | Method of manufacturing an implant for use in a surgical procedure |
| EP3042622B1 (en) | 2015-01-09 | 2018-05-09 | Stryker European Holdings I, LLC | Implant for bone fixation |
| BR102016012926B1 (pt) * | 2016-06-06 | 2019-04-02 | Brunella Sily De Assis Bumachar | Processo de deposição nanométrica de fosfato de cálcio na superfície de implante de titânio anodizado |
| IT201600091766A1 (it) * | 2016-09-12 | 2018-03-12 | Innovaplants Srl | Dispositivi medici impiantabili aventi uno strato di rivestimento con proprieta' antimicrobiche a base di idrossiapatite nanostrutturata. |
| EP3320868B1 (en) | 2016-11-11 | 2019-05-01 | Stryker European Holdings I, LLC | Implant for bone fixation |
| EP3908338A4 (en) * | 2019-01-10 | 2022-09-07 | University of Utah Research Foundation | FLUORAPATITE-COATED IMPLANTS AND METHODS RELATING TO FEDERALLY FUNDED RESEARCH |
| CN110302424A (zh) * | 2019-07-29 | 2019-10-08 | 西南交通大学 | 一种高通量仿生矿化多元素掺杂钙磷涂层的制备方法 |
| CN111467573A (zh) * | 2020-04-21 | 2020-07-31 | 上海交通大学医学院附属第九人民医院 | 一种用于预防种植体周围炎发生的口腔种植体 |
| CN112723315A (zh) * | 2020-11-16 | 2021-04-30 | 山东和创智云环保装备有限公司 | 一种臭氧发生用金属及其原位生长陶瓷介电体一体化电极及其制作工艺 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004358249A (ja) * | 2003-05-30 | 2004-12-24 | Depuy Products Inc | ストロンチウム置換アパタイト被覆 |
| JP2009511420A (ja) * | 2005-10-18 | 2009-03-19 | フィン−セラミカ ファエンツァ エス．ピー．エー． | 多置換されたヒドロキシアパタイトと、天然および／または合成ポリマーとの複合体と、それらの生成および使用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1288038B1 (it) * | 1996-04-30 | 1998-09-10 | Flametal S P A | Procedimento per la preparazione di rivestimenti di idrossiapatite |
| GB2316940A (en) * | 1996-08-30 | 1998-03-11 | Queen Mary & Westfield College | Silicon-substituted hydroxyapatite |
| US6013591A (en) * | 1997-01-16 | 2000-01-11 | Massachusetts Institute Of Technology | Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production |
| US6139585A (en) * | 1998-03-11 | 2000-10-31 | Depuy Orthopaedics, Inc. | Bioactive ceramic coating and method |
| US6736849B2 (en) * | 1998-03-11 | 2004-05-18 | Depuy Products, Inc. | Surface-mineralized spinal implants |
| JP2000093503A (ja) * | 1998-09-15 | 2000-04-04 | Isotis Bv | 医療用インプラントをコ―トする方法 |
| US20080241353A1 (en) * | 2004-08-10 | 2008-10-02 | Yekimed Ag | Biomimetic Process For Coating Substrates With A Biomimetic Solution Containing A Bioactive Substance And Use Of Said Process And Substrates In Bone, Connective Tissue-, Fat Tissue-And Muscle Tissue Engineering |
-
2009
- 2009-04-27 SE SE0900560A patent/SE535536C2/sv not_active IP Right Cessation
-
2010
- 2010-04-26 JP JP2012508432A patent/JP2012525201A/ja active Pending
- 2010-04-26 US US13/266,533 patent/US20120087954A1/en not_active Abandoned
- 2010-04-26 CN CN2010800188222A patent/CN102438671A/zh active Pending
- 2010-04-26 EP EP10770028.8A patent/EP2424580A4/en not_active Withdrawn
- 2010-04-26 WO PCT/SE2010/050461 patent/WO2010126436A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004358249A (ja) * | 2003-05-30 | 2004-12-24 | Depuy Products Inc | ストロンチウム置換アパタイト被覆 |
| JP2009511420A (ja) * | 2005-10-18 | 2009-03-19 | フィン−セラミカ ファエンツァ エス．ピー．エー． | 多置換されたヒドロキシアパタイトと、天然および／または合成ポリマーとの複合体と、それらの生成および使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2424580A1 (en) | 2012-03-07 |
| EP2424580A4 (en) | 2014-04-16 |
| CN102438671A (zh) | 2012-05-02 |
| WO2010126436A1 (en) | 2010-11-04 |
| SE535536C2 (sv) | 2012-09-11 |
| US20120087954A1 (en) | 2012-04-12 |
| SE0900560A1 (sv) | 2010-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012525201A (ja) | イオン置換されたリン酸カルシウムコーティング | |
| Ratnayake et al. | Substituted hydroxyapatites for bone regeneration: A review of current trends | |
| Liu et al. | The role of surface functional groups in calcium phosphate nucleation on titanium foil: a self-assembled monolayer technique | |
| Campbell | Bioceramics for implant coatings | |
| Ran et al. | Strontium-doped hydroxyapatite and its role in osteogenesis and angiogenesis | |
| Feng et al. | Controlled crystal growth of calcium phosphate on titanium surface by NaOH-treatment | |
| Bulina et al. | Lanthanum–silicate–substituted apatite synthesized by fast mechanochemical method: Characterization of powders and biocoatings produced by micro–arc oxidation | |
| da Rocha et al. | Bioactivity of strontium-monetite coatings for biomedical applications | |
| Durgalakshmi et al. | Nano-bioglass: a versatile antidote for bone tissue engineering problems | |
| Wei et al. | Structures, bonding strength and in vitro bioactivity and cytotoxicity of electrochemically deposited bioactive nano-brushite coating/TiO2 nanotubes composited films on titanium | |
| Tovani et al. | Sr2+-substituted CaCO3 nanorods: impact on the structure and bioactivity | |
| Wu et al. | In vitro bioactivity of anatase film obtained by direct deposition from aqueous titanium tetrafluoride solutions | |
| Moloodi et al. | Evaluation of fluorohydroxyapatite/strontium coating on titanium implants fabricated by hydrothermal treatment | |
| Harding et al. | Bioinspired deposition-conversion synthesis of tunable calcium phosphate coatings on polymeric hydrogels | |
| dos Santos et al. | Calcium phosphates of biological importance based coatings deposited on Ti-15Mo alloy modified by laser beam irradiation for dental and orthopedic applications | |
| Li et al. | Hydroxyapatite-whitlockite composite coating as a biomimetic material for bone integration | |
| Elyada et al. | Polyelectrolyte multilayer-calcium phosphate composite coatings for metal implants | |
| Cui et al. | Effect of hot water and heat treatment on the apatite-forming ability of titania films formed on titanium metal via anodic oxidation in acetic acid solutions | |
| Saneei et al. | Titanium dioxide nanotubes incorporated bioactive glass nanocomposites: synthesis, characterization, bioactivity evaluation and drug loading | |
| Forsgren et al. | A novel method for local administration of strontium from implant surfaces | |
| Layrolle et al. | Physicochemistry of apatite and its related calcium phosphates | |
| Liu et al. | In vitro surface reaction layer formation and dissolution of calcium phosphate cement–bioactive glass composites | |
| CN101642586A (zh) | 一种制备含硅羟基磷酸钙涂层的仿生溶液及仿生方法 | |
| Navarro et al. | Biomimetic mineralization of ceramics and glasses | |
| Arshad et al. | Silicon-substituted hydroxyapatite |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130426 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130426 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140603 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20141028 |